Inventor · disambiguated record
Mary-Margaret Zablocki
Also filed as: ZABLOCKI MARY-MARGARET · ZABLOCKI MARY-MARGARET E
51 granted patents·7 pending applications·470 citations·filing 2008–2025
99Inventor score
Files withFORMA THERAPEUTICS INC33VALO HEALTH INC10VALO EARLY DISCOVERY INC9CONSTELLATION PHARMACEUTICALS INC3ACCENT THERAPEUTICS INC1
Top patents by PatentIndex Score
58 records- 0199US10829461B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·15 cites·12 claims
- 0299US10829462B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·15 cites·17 claims
- 0399US10377726B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·22 cites·10 claims
- 0499US10112915B23-aryl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Oct 30, 2018·41 cites·31 claims
- 0598US11279681B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Mar 22, 2022·6 cites·20 claims
- 0698US10822316B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 3, 2020·10 cites·15 claims
- 0798US10494354B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·17 cites·17 claims
- 0898US10494353B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·17 cites·12 claims
- 0998US10472337B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 12, 2019·17 cites·12 claims
- 1098US10428031B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 1, 2019·15 cites·20 claims
- 1198US10421731B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·15 cites·19 claims
- 1298US10421732B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 24, 2019·16 cites·13 claims
- 1398US10414738B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Sep 17, 2019·16 cites·20 claims
- 1498US10239845B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Mar 26, 2019·25 cites·42 claims
- 1598US10214501B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·20 cites·38 claims
- 1698US10214500B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Feb 26, 2019·20 cites·35 claims
- 1797US10988450B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·6 cites·14 claims
- 1897US10513501B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·11 cites·20 claims
- 1997US10494352B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·12 cites·20 claims
- 2097US10494351B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 3, 2019·12 cites·20 claims
- 2197US10464910B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·15 claims
- 2297US10464909B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2019·12 cites·17 claims
- 2397US10457652B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 29, 2019·12 cites·18 claims
- 2497US10450283B23-alkyl bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 22, 2019·14 cites·16 claims
- 2597US10450284B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 22, 2019·14 cites·13 claims
- 2697US10442776B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Oct 15, 2019·15 cites·18 claims
- 2796US12213969B22-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitorsVALO HEALTH INC·Filed 2023·Granted Feb 4, 2025·2 cites·20 claims
- 2896US11730721B22-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Aug 22, 2023·3 cites·20 claims
- 2996US11299484B2Inhibiting fatty acid synthase (FASN)FORMA THERAPEUTICS INC·Filed 2020·Granted Apr 12, 2022·3 cites·22 claims
- 3094US10479772B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Nov 19, 2019·6 cites·13 claims
- 3193US10874649B22-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Dec 29, 2020·9 cites·15 claims
- 3293US10555935B22-spiro-5- and 6-hydroxamic acid indanes as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2017·Granted Feb 11, 2020·11 cites·17 claims
- 3393US9745253B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Aug 29, 2017·10 cites·53 claims
- 3492US11891365B23-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2021·Granted Feb 6, 2024·1 cites·23 claims
- 3589US11274084B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Mar 15, 2022·1 cites·18 claims
- 3688US10266487B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 23, 2019·4 cites·16 claims
- 3785US12264137B23-aryl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2022·Granted Apr 1, 2025·0 cites·17 claims
- 3885US10988441B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Apr 27, 2021·1 cites·20 claims
- 3985US10501424B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2019·1 cites·17 claims
- 4085US10029995B2[6,6] fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Granted Jul 24, 2018·3 cites·39 claims
- 4184US10508077B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Dec 17, 2019·2 cites·20 claims
- 4284US10370343B2[6,6] Fused bicyclic HDAC8 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 6, 2019·2 cites·18 claims
- 4382US11524966B1Carboxamides as ubiquitin-specific protease inhibitorsVALO EARLY DISCOVERY INC·Filed 2018·Granted Dec 13, 2022·2 cites·15 claims
- 4482US10875848B2Inhibiting fatty acid synthase (FASN)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 29, 2020·1 cites·30 claims
- 4582US10829460B2[6,6] fused bicyclic HDAC8 inhibitorsVALO EARLY DISCOVERY INC·Filed 2019·Granted Nov 10, 2020·1 cites·20 claims
- 4682US2023406830A1[6,6] fused bicyclic hdac8 inhibitorsVALO HEALTH INC·Filed 2023·Application pending·0 cites
- 4780US11919839B2Alpha-cinnamide compounds and compositions as HDAC8 inhibitorsVALO HEALTH INC·Filed 2021·Granted Mar 5, 2024·0 cites·20 claims
- 4879US11274085B23-aryl-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitorsVALO HEALTH INC·Filed 2020·Granted Mar 15, 2022·0 cites·15 claims
- 4973US11414392B2[6,6] fused bicyclic HDAC8 inhibitorsVALO HEALTH INC·Filed 2020·Granted Aug 16, 2022·0 cites·20 claims
- 5073US2022315565A1Inhibiting fatty acid synthase (fasn)FORMA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Mary-Margaret Zablocki files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →